A pharmaceutical formulation contains ramipril principally in the form of a ramipril salt and is buffered at basic pH. Ramipril in the formulation degrades preferentially to the diacid, ramiprilat, rather than the diketopiperazine.
申请公布号
WO2007045907(A3)
申请公布日期
2007.08.30
申请号
WO2006GB03927
申请日期
2006.10.23
申请人
SELAMINE LIMITED;TABATZNIK, ANTHONY, S.;HARRISON, PAUL, JONATHAN;POWER, ANNA, MARIE, ELIZABETH
发明人
HARRISON, PAUL, JONATHAN;POWER, ANNA, MARIE, ELIZABETH